1. Introduction {#sec1}
===============

Of late due to the constant emergence of antibiotics resistance to clinically used compounds, it is the need of the hour to develop novel antibiotics classes, which eventually would target the lipoid layer of the organisms and other aspects of pathogens\' life cycle. Metal complexes may be subjected for the design and synthesis of such possibilities having such biological activities \[[@B1]--[@B3]\]. The chemistry of Schiff bases and their structural analogues has occupied a place of considerable importance \[[@B4]\] as they easily form stable complexes with most transition metal ions \[[@B5], [@B6]\] and well-established biological properties. 1,2,4-triazoles nucleus and their derivatives emerge rapidly with the advances of modern heterocyclic chemistry, promising a variety of medical applications such as antibacterial, antifungal, anticancer, antitumor, anticonvulsant, anti-inflammatory, and analgesic properties \[[@B7]--[@B12]\]. Schiff bases of 1,2,4-triazoles find diverse applications and extensive biological activity. The incorporation of the 1,2,4-triazole unit into Schiff base macrocycles is of considerable current interest as complexes of 1,2,4-triazoles are being developed for potential use in applications such as magnetic materials and photo chemically driven molecular devices \[[@B13]\]. Schiff bases derived from 3-substituted-4-amino-5-mercapto-1,2,4-triazoles show analgesic, antimicrobial, anti-inflammatory, and antidepressant activities \[[@B14]\].

The aim of the present study was to modify the bioactivities of 1,2,4-triazole Schiff bases and gain the relative derivatives with better curing effect, optimization of hydrophilic/lipophilic character, and improve the bioavailability by coordinating them with transition metal ions. During the course of this work, a series of cobalt, nickel, copper, and zinc complexes of bidentate Schiff bases derived from the condensation reaction of 4-amino-5-mercapto-3-methyl/ethyl-1, 2, 4-triazole with 2, 4-dichlorobenzaldehyde have been synthesized. The synthesized Schiff bases and their metal complexes were characterized with the aid of elemental analyses, magnetic moment measurements, spectroscopic, and thermogravimetric techniques. The Schiff bases and their metal complexes have been screened for antibacterial (*Pseudomonas aeruginosa*, *Bacillus subtilis*) and antifungal activities (*Aspergillus niger*, *A. flavus*).

2. Experimental {#sec2}
===============

2.1. Materials and Methods {#sec2.1}
--------------------------

All the chemicals used in the present investigation were of Analytical grade and used without further purification. The metal contents were determined using standard gravimetric methods; cobalt was estimated as cobalt pyridine thiocyanate, nickel as nickel dimethylglyoximate, copper as cuprous thiocyanate, and zinc as zinc ammonium phosphate \[[@B15]\].

The Perfit electrical melting point apparatus is used to record melting points of the synthesized complexes and are uncorrected. Carbon, hydrogen, and nitrogen were estimated using Perkin-Elmer 2400 Elemental Analyzer at Punjab University, Chandigarh. Electronic spectra of metal complexes were recorded in DMF on a Systronics 2203 double-beam spectrophotometer in the region 1100--200 nm. IR spectra were recorded on a MB-3000 ABB spectrometer in KBr/Nujol mulls in the range 4000--250 cm^−1^. Proton NMR spectra were recorded in DMSO-d~6~ on a Bruker ACF 300 spectrometer at 300 MHz using "tetramethyl silane" as the internal standard. Magnetic moments were measured at Institute Instrumentation Centre, IIT Roorkee on vibrating sample magnetometer (Model 155). The Perkin Elmer (Pyris Diamond) instrument was used to carry out thermal analysis of metal complexes in atmospheric air at the heating rate of 10°C Min^−1^ using a reference to alumina powder. The EPR spectrum of the copper(II) complex was recorded at SAIF, IIT, Bombay, using VARIAN E-112 X-band EPR spectrometer with cylindrical quartz sample tube operating at microwave frequency 9.5 GHz. Field calibration was checked using tetracyanoethylene (TCNE) free radical for which *g* = 2.0027 at room temperature.

2.2. Syntheses {#sec2.2}
--------------

4-Amino-5-mercapto-3-methyl-1,2,4-triazole (*ammt*) and 4-amino-3-ethyl-5-mercapto-1,2,4-triazole (*aemt*) were prepared by reported literature method \[[@B16]\].

### 2.2.1. 4-\[(2,4-Dichloro-benzylidene)-amino\]-5-mercapto-3-methyl-1,2,4-triazole (HL^1^) {#sec2.2.1}

An ethanolic solution (40 mL) of *ammt* (1.08 g, 8.33 mmol) was treated with 2,4-dichlorobenzaldehyde (1.45 g, 8.33 mmol). The reaction mixture was refluxed for 3 h, and then the clear solution was allowed to cool to room temperature. The solid material formed was removed by filtration, washed with cold ethanol, and recrystallized from ethanol and dried ([Figure 1](#fig1){ref-type="fig"}).

m.p. 249--252°C, (found: C, 41.78; H, 2.78; N, 19.46%. Calcd. For C~10~H~8~Cl~2~N~4~S: C, 41.82; H, 2.81; N, 19.51%); MS: m/z (M + 1) 286.9, (M − 1) 284.9.

### 2.2.2. 4-\[(2,4-Dichloro-benzylidene)-amino\]-3-ethyl-5-mercapto-1,2,4-triazole (HL^2^) {#sec2.2.2}

An ethanolic solution of *aemt* (1.41 g, 9.79 mmol) was added with stirring to an ethanolic solution of 5-nitro-furfuraldehyde (1.71 g, 9.79 mmol) and refluxed for 3 h, and the product was filtered off, washed with ice cold ethanol, and a light yellow crystalline product was obtained after recrystallization from ethanol ([Figure 1](#fig1){ref-type="fig"}).

m.p. 236--239°C, (found: C, 43.22; H, 3.28; N, 18.43%. calcd. For C~11~H~10~Cl~2~N~4~S: C, 43.86; H, 3.35; N, 18.60%); MS: m/z (M + 1) 300.9, (M − 1) 298.9.

### 2.2.3. Syntheses of Metal Complexes of \[HL^1^\] (1 : 1) {#sec2.2.3}

The hot ethanolic solutions of the HL^1^ (0.22 g, 0.76 mmol) were slowly added to the aqueous ethanolic solutions of acetates of Co(II) (0.19 g, 0.76 mmol), Ni(II) (0.19 g, 0.76 mmol), Cu(II) (0.15 g, 0.76 mmol), and Zn(II) (0.16 g, 0.76 mmol), which resulted in the immediate precipitation of metal derivatives. The products formed were filtered and purified by washing thoroughly with warm water, with aqueous ethanol to remove unreacted metal acetates or ligands, and finally with acetone and dried.

Co(L^1^)OAc·3H~2~O: (found: C, 31.28; H, 3.38; N, 12.10; Co, 12.78% calcd. For C~12~H~16~Cl~2~CoN~4~O~5~S: C, 31.46; H, 3.52; N, 12.23; Co, 12.86%).

Ni(L^1^)OAc·3H~2~O: (found: C, 31.38; H, 3.43; N, 12.16; Ni, 12.72% calcd. For C~12~H~16~Cl~2~N~4~NiO~5~S: C, 31.47; H, 3.52; N, 12.23; Ni, 12.82%).

Cu(L^1^)OAc·H~2~O: (found: C, 39.44; H, 2.68; N, 16.88; Cu, 9.54% calcd. For C~12~H~12~Cl~2~CuN~4~O~3~S: C, 39.80; H, 2.73; N, 16.88; Cu, 9.57%).

Zn(L^1^)OAc·3H~2~O: (found: C, 30.99; H, 3.41; N, 11.96; Zn, 14.00% calcd. For C~12~H~16~Cl~2~N~4~O~5~SZn: C, 31.02; H, 3.47; N, 12.06; Zn, 14.07%).

### 2.2.4. Syntheses of Metal Complexes of \[HL^1^\] (1 : 2) {#sec2.2.4}

The aqueous ethanolic solutions of acetates of Co(II) (0.17 g, 0.69 mmol), Ni(II) (0.17 g, 0.69 mmol), Cu(II) (0.14 g, 0.69 mmol) and Zn(II) (0.15 g, 0.69 mmol) were treated with the hot ethanolic solutions of the HL^1^ (0.40 g, 1.39 mmol). The products formed were filtered and purified by washing thoroughly with warm water, with aqueous ethanol to remove unreacted metal acetates or ligands and finally with acetone and dried.

Co(L^1^)~2~·2H~2~O: (found: C, 35.88; H, 2.67; N, 16.73; Co, 8.80% calcd. For C~20~H~18~Cl~4~CoN~8~O~2~S~2~: C, 36.00; H, 2.72; N, 16.79; Co, 8.83%).

Ni(L^1^)~2~·2H~2~O: (found: C, 36.00; H, 2.62; N, 16.55; Ni, 8.76% calcd. For C~20~H~18~Cl~4~N~8~NiO~2~S~2~: C, 36.01; H, 2.72; N, 16.80; Ni, 8.80%).

Cu(L^1^)~2~: (found: C, 33.65; H, 2.77; N, 13.61; Cu, 14.77% calcd. For C~20~H~14~Cl~4~CuN~8~S~2~: C, 33.77; H, 2.83; N, 13.63; Cu, 14.89%).

Zn(L^1^)~2~·2H~2~O: (found: C, 35.60; H, 2.61; N, 16.58; Zn, 9.68% calcd. For C~20~H~18~Cl~4~N~8~O~2~S~2~Zn: C, 35.65; H, 2.69; N, 16.63; Zn, 9.71%).

### 2.2.5. Syntheses of Metal Complexes of \[HL^2^\] (1 : 1) {#sec2.2.5}

The hot ethanolic solutions of the HL^2^ (0.31 g, 1 mmol) were added to the aqueous ethanolic solutions of acetates of Co(II) (0.25 g, 1 mmol), Ni(II) (0.25 g, 1 mmol), Cu(II) (0.20 g, 1 mmol) and Zn(II) (0.22 g, 1 mmol), which resulted in the immediate precipitation of metal derivatives. The products formed were filtered and purified by washing thoroughly with warm water, with aqueous ethanol to remove unreacted metal acetates or ligands and finally with acetone and dried.

Co(L^2^)OAc·3H~2~O: (found: C, 33.00; H, 3.84; N, 11.77; Co, 12.43% calcd. For C~13~H~18~Cl~2~CoN~4~O~5~S: C, 33.07; H, 3.84; N, 11.86; Co, 12.48%).

Ni(L^2^)OAc·3H~2~O: (found: C, 32.97; H, 3.81; N, 11.81; Ni, 12.44% calcd. For C~13~H~18~Cl~2~N~4~NiO~5~S: C, 33.08; H, 3.84; N, 11.87; Ni, 12.44%).

Cu(L^2^)OAc·H~2~O: (found: C, 35.42; H, 3.18; N, 12.20; Cu, 14.48% calcd. For C~13~H~14~Cl~2~CuN~4~O~3~S: C, 35.42; H, 3.20; N, 12.71; Cu, 14.42%).

Zn(L^2^)OAc·3H~2~O: (found: C, 32.60; H, 3.78; N, 15.73; Zn, 9.31% calcd. For C~13~H~18~Cl~2~N~4~O~5~SZn: C, 32.62; H, 3.79; N, 15.97; Zn, 9.32%).

### 2.2.6. Syntheses of Metal Complexes of \[HL^2^\] (1 : 2) {#sec2.2.6}

The aqueous ethanolic solutions of acetates of Co(II) (0.20 g, 0.83 mmol), Ni(II) (0.20 g, 0.83 mmol), Cu(II) (0.16 g, 0.83 mmol), and Zn(II) (0.18 g, 0.83 mmol) were treated with the hot ethanolic solutions of the HL^2^ (0.50 g, 1.6 mmol). The products formed were filtered and purified by washing thoroughly with warm water, with aqueous ethanol to remove unreacted metal acetates or ligands, and finally with acetone and dried.

Co(L^2^)~2~·2H~2~O: (found: C, 37.77; H, 3.18; N, 16.13; Co, 8.48% calcd. For C~22~H~22~Cl~4~CoN~8~O~2~S~2~: C, 38.00; H, 3.19; N, 16.12; Co, 8.48%).

Ni(L^2^)~2~·2H~2~O: (found: C, 38.80; H, 3.15; N, 16.14; Ni, 8.45% calcd. For C~22~H~22~Cl~4~N~8~NiO~2~S~2~: C, 38.81; H, 3.19; N, 16.12; Ni, 8.44%).

Cu(L^2^)~2~: (found: C, 39.21; H, 2.88; N, 16.83; Cu, 9.55% calcd. For C~22~H~18~Cl~4~CuN~8~S~2~: C, 39.80; H, 2.73; N, 16.88; Cu, 9.57%).

Zn(L^2^)~2~·2H~2~O: (found: C, 37.66; H, 3.15; N, 15.95; Zn, 9.32% calcd. For C~22~H~22~Cl~4~N~8~O~2~S~2~Zn: C, 37.65; H, 3.16; N, 15.97; Zn, 9.31%).

2.3. Antimicrobial Assay {#sec2.3}
------------------------

### 2.3.1. Test Microorganisms {#sec2.3.1}

Four microbial strains were selected on the basis of their clinical importance in causing diseases in humans. Two bacteria (*Staphylococcus aureus*MTCC 96 and *Bacillus subtilis*MTCC 121) and two fungi, *Aspergillus niger*and*A. flavus*, the ear pathogens isolated from the patients of Kurukshetra \[[@B17]\], were used in the present study for evaluation of antimicrobial activity of the synthesized compounds. All the bacterial cultures were procured from Microbial Type Culture Collection (MTCC), IMTECH, Chandigarh. The bacteria were subcultured on Nutrient agar, whereas fungi on Sabouraud\'s dextrose agar.

### 2.3.2. Antibacterial Activity {#sec2.3.2}

The antibacterial activity of all the synthesized complexes was evaluated by using agar well-diffusion method. All the microbial cultures were adjusted to 0.5 McFarland standard, which is visually comparable to a microbial suspension of approximately 1.5 × 10^8^ cfu/mL. 20 mL of Mueller Hinton agar medium was poured into each Petri plate and plates were swabbed with 100 *μ*L inocula of the test microorganisms and kept for 15 min for adsorption. Using sterile cork borer of 8 mm diameter, wells were bored into the seeded agar plates, and these were loaded with a 100 *μ*L volume with concentration of 4.0 mg/mL of each compound reconstituted in the dimethylsulphoxide (DMSO). All the plates were incubated at 37°C for 24 hrs. Antibacterial activity of each compound was evaluated by measuring the zone of growth inhibition against the test organisms with zone reader (HiAntibiotic zone scale). DMSO was used as a negative control whereas Ciprofloxacin was used as positive control. This procedure was performed in three replicate plates for each organism \[[@B18], [@B19]\].

### 2.3.3. Minimum Inhibitory Concentration (MIC) Determination {#sec2.3.3}

MIC of all the compounds against bacterial strains was tested through a modified agar well-diffusion method \[[@B20]\]. In this method, a twofold serial dilution of each compound was prepared by first reconstituting the compound in DMSO followed by dilution in sterile distilled water to achieve a decreasing concentration range of 256 to 0.5 *μ*g/mL. A 100 *μ*L volume of each dilution was introduced into wells (in triplicate) in the agar plates already seeded with 100 *μ*L of standardized inoculums (10^6^ cfu/mL) of the test microbial strain. All test plates were incubated aerobically at 37°C for 24 hrs and observed for the inhibition zones. MIC, taken as the lowest concentration of the chemical compound that completely inhibited the growth of the microbe, showed by a clear zone of inhibition, was recorded for each test organism. Ciprofloxacin was used as positive control.

### 2.3.4. Antifungal Activity {#sec2.3.4}

The antifungal activity of Schiff bases and their metal complexes was evaluated by poison food technique \[[@B21]\]. The molds were grown on Sabouraud\'s dextrose agar (SDA) at 25°C for 7 days and used as inocula. The 15 mL of molten SDA (45°C) was poisoned by the addition of 100 *μ*L volume of each compound having concentration of 4.0 mg/mL reconstituted in DMSO, poured into a sterile Petri plate, and allowed it to solidify at room temperature. The solidified poisoned agar plates were inoculated at the center with fungal plugs (8 mm diameter) obtained from the colony margins and incubated at 25°C for 7 days. DMSO was used as the negative control whereas fluconazole was used as the positive control. The experiments were performed in triplicates. Diameter of fungal colonies was measured and expressed as percent mycelial inhibition.

Percent inhibition of mycelial growth = (dc − dt)/dc × 100.

dc: average diameter of fungal colony in negative control sets.

dt: average diameter fungal colony in experimental sets.

3. Results and Discussion {#sec3}
=========================

The Schiff bases ([Figure 1](#fig1){ref-type="fig"}) were soluble in ethanol and methanol. All the metal complexes are colored, nonhygroscopic solids stable in air, insoluble in water and many common organic solvents but soluble in DMF and DMSO, decomposed at higher temperature. The elemental analysis supports the formation of 1 : 1 and 1 : 2 metal complexes of HL^1-2^ with Co(II), Ni(II), Cu(II), and Zn(II) metal ions. The molar conductance values of the complexes (measured in 10^−3^ M DMF) are in the range 1.5--3.6 ohm^−1^ cm^2^ mol^−1^ indicating the nonelectrolytic nature \[[@B22]\]. The purity of ligands and their metal complexes has been checked by TLC.

3.1. IR Spectra {#sec3.1}
---------------

The IR spectral data of the Schiff base ligands and their complexes are listed in [Table 1](#tab1){ref-type="table"}. The IR spectra of the complexes have been compared with those of the free ligand in order to determine the coordination sites that may get involved in chelation. By comparing, it was found that azomethine group frequency *ν*(N=CH) is present in the free ligands at 1595--1597 cm^−1^. This band is shifted to the lower frequency (22--24) by 5--15 cm^−1^ in the spectra of the complexes, indicating coordination of azomethine nitrogen towards the metal ion (M--N).

A new band at 485--514 cm^−1^ due to *ν*(M--N) is further confirmed the coordination of metal to azomethine nitrogen. The Schiff bases exhibit a weak broad band around \~2700 cm^−1^ due to *ν*(S--H) vibrations \[[@B23], [@B25]\]. This band disappeared in the spectra of the metal complexes indicating deprotonation and complexation through sulphur. In the spectra of metal complexes, bands appeared at 733--771 cm^−1^ and 334--352 cm^−1^ were assigned to *ν*(C--S) and *ν*(M--S), respectively \[[@B22], [@B24]\]. In the spectra of metal complexes, a broad band in the region 3200--3490 cm^−1^ indicated the presence of coordinated water molecules. A strong band in the region 1738--1750 cm^−1^ has been assigned to *ν*(OOCCH~3~) in 1 : 1 metal complexes.

3.2. ^1^H NMR Spectra {#sec3.2}
---------------------

The ^1^H NMR spectra have been recorded for Schiff bases and Zn(II) complexes ([Table 2](#tab2){ref-type="table"}). The NMR spectra of metal complexes indicated a shift of electron density from the ligand to metal. The ligands \[HL^1-2^\] showed characteristic azomethine proton singlet at *δ* 10.40 and 10.55 ppm, respectively. The characteristic signal, due to azomethine proton deshielded in the spectra of metal complexes, suggests coordination of metal ion to azomethine nitrogen atom \[[@B23], [@B24], [@B26]\]. In addition to this, the signal at *δ* 11.10--11.09 ppm is ascribed to SH proton. Disappearance of SH protons signal in the spectra of metal complexes supported the deprotonation of thiol group and chelation with metal (M--S). The aromatic protons of Schiff bases appeared as a double of doublet and two doublets at *δ* 7.35, 7.52 and 8.08 ppm, respectively. These aromatic protons signals show a slight downfield shift upon coordination. In the spectra of 1 : 1 Zn complexes singlet at *δ* 2.29 and 2.32 ppm are due to methyl group of acetate ion.

3.3. Magnetic Measurements and Electronic Spectra {#sec3.3}
-------------------------------------------------

The magnetic moment measurements and electronic spectra provided good information regarding the arrangements of the ligands around the metal ions ([Table 3](#tab3){ref-type="table"}). The 1 : 1 and 1 : 2 Co(II) complexes show magnetic moment (*μ* ~eff.~) 4.83--4.95 BM, well within the expected range of octahedral complex (4.3--5.2 BM) \[[@B25], [@B27]\]. Co(II) complexes exhibit two absorption bands in the region 10885--10935 cm^−1^ (*ν* ~1~) and 20010--20998 cm^−1^ (*ν* ~3~), which are assigned to ^4^T~1g~(F) → ^4^T~2g~(F) (*ν* ~1~); ^4^T~1g~(F) → ^4^T~1g~(P) (*ν* ~3~) transitions \[[@B23]--[@B24], [@B27]\]. These are the characteristic bands of high spin octahedral Co(II) complexes; *ν* ~2~ is not observed, but it can be calculated \[[@B28], [@B29]\] by using relation *ν* ~2~ = *ν* ~1~ + 10Dq, which is very close to (*ν* ~3~) transition. The ligand field parameters (Dq, B, *β*, *β*%) have also been calculated for Co(II) complexes by using Band-fitting equation \[[@B30]\]. The crystal field stabilizing energy (Dq) value was found to be \~1200 cm^−1^. These values are well within the range reported for the octahedral complexes \[[@B30]\]. The Racah parameter (B) is found to be 683--755 cm^−1^ (\<971 cm^−1^), suggesting an overlapping of ligand metal orbital\'s. The nephelauxetic ratio (*β*) for the 1 : 1 and 1 : 2 cobalt complexes is less than one suggesting partial covalency in the metal ligand bond.

The nickel complexes show magnetic moment in the range 3.43--3.47 BM, which corresponds to octahedral environment around the central metal ion. Nickel(II) complexes generally show three absorption bands in octahedral environment corresponding to ^3^A~2g~(F) → ^3^T~2g~(F) (*ν* ~1~), ^3^A~2g~(F) → ^3^T~1g~(F) (*ν* ~2~) and ^3^A~2g~(F) → 3T~1g~(P) (*ν* ~3~) transitions \[[@B28]\]. The 1 : 1 and 1 : 2 Ni(II) complexes of HL^1-2^ Schiff bases also show above three transitions in the region 9999--10123 cm^−1^ (*ν* ~1~), 16380--17320 cm^−1^ (*ν* ~2~), and 24885--24993 cm^−1^ (*ν* ~3~), suggesting distorted octahedral geometry for the complexes. The ligand field parameters (Dq, B, *β*, *β*%) have also been calculated for Ni(II) complexes by using Band-fitting equation \[[@B30]\]. These parameters indicate significant covalent character of the metal ligand bonds.

The Cu(II) complex has magnetic moment value 1.92--2.11 BM, which fall in the normal range (1.7--2.2 BM). The electronic spectra of Cu(II) complexes showed broad band around 18550 cm^−1^, which is assigned to ^2^B~1g~ → ^2^A~1g~ (*ν* ~1~) transition. It is a characteristic band of square planar geometry around the Cu(II) \[[@B31]\].

3.4. Thermal Studies {#sec3.4}
--------------------

Thermogravimetric analysis was carried out for Cu(L^2^)~2~ and Zn(L^1^)~2~·2H~2~O ([Figure 2](#fig2){ref-type="fig"}) from 80°C to 700°C in atmospheric air \[[@B22], [@B23], [@B24]\]. The decomposition temperature, pyrolysed products, percentage mass loss of the complexes, and the ash (percent) are given in [Table 4](#tab4){ref-type="table"}. The thermograms for both of these complexes show three decomposition steps. In case of Cu(L^2^)~2~ complex, the first step 50--305°C results in a mass loss of 45.29% (calcd. 47.90%) corresponding to a loss organic moiety. The 2nd and 3rd steps (305--695°C) correspond to removal of two triazole molecules with mass loss of 40.32% (calcd. 42.52%) of the ligand leaving metal oxide as residue.

In case of Zn(L^1^)~2~·2H~2~O complex, the first step 50--230°C results in a mass loss of 4.98% (calcd. 5.37%) corresponding to loss of two water molecules. The 2nd steps corresponds to loss of organic moiety with mass loss 51.50% (calcd. 51.30%) in the temperature range 230--560°C. The 3rd step (560--700°C) corresponds to removal of two triazole molecules with mass loss of 31.12% (calcd. 33.73%). The decomposition of both of the complexes ended with oxide formation.

3.5. ESR Spectra {#sec3.5}
----------------

ESR spectra of 1 : 1 and 1 : 2 copper(II) complexes in solid state at 298 K show an intense broad signal having no hyperfine structure. The observed g values for Cu(L^1^)(OAc)·H~2~O at room temperature are *g* ~\|\|~ = 2.18, *g* ~⊥~ = 2.10, *g* ~av~ = 2.12, *G* = 1.81 and for Cu(L^1^)~2~ at room temperature are *g* ~\|\|~ =2.19, *g* ~⊥~ = 2.12, *g* ~av~ = 2.14, *G* = 1.59. The trend in *g* values (*g* ~\|\|~ \> *g* ~⊥~ \> 2.00) suggested that the unpaired electron is localized in the *dx* ^2^-*y* ^2^ orbital and corresponds to square planar geometry of the complexes. The *g* ~\|\|~ \< 2.3 value confirms the covalent character of the metal ligand bond. The axial symmetry parameter *G* is less than 4.0, indicates considerable exchange interaction in the solid complex \[[@B32]\].

3.6. Antimicrobial Discussion {#sec3.6}
-----------------------------

The Schiff bases and their metal complexes were screened for their antibacterial and antifungal activity. All the tested chemical compounds possessed variable antibacterial activity against *Staphylococcus aureus, Bacillus subtilis* and antifungal activity against *Aspergillus niger* and *Aspergillus flavus.* However the compounds in this series were not effective against any Gram-negative bacteria (*E. coli*and *P. aeruginosa*). Positive controls produced significantly sized inhibition zones against the tested bacteria and fungi; however, negative control produced no observable inhibitory effect against any of the test organism as shown in Tables [5](#tab5){ref-type="table"}, [6](#tab6){ref-type="table"}, and [7](#tab7){ref-type="table"}.

The tested chemical compounds showed zone of inhibition ranging between 15 and 26 mm against the Gram positive bacteria. On the basis of zone of inhibition produced against the test bacterium, Co(L^1^)(OAc)·3H~2~O and Zn(L^1^)(OAc)·3H~2~O were found to be most effective against *S. aureus* with zone of inhibition ranging between 23.6 mm and 20.6 mm, respectively, and four compounds HL^1^, Co(L^1^)(OAc)·3H~2~O, Zn(L^1^)(OAc)·3H~2~O and Zn(L^2^)(OAc)·3H~2~O were found to be best against *B. subtilis*, with zone of inhibition ranging between 21.6 mm and 23.6 mm ([Table 5](#tab5){ref-type="table"}). In the whole series, the MIC of chemical compounds ([Figure 3](#fig3){ref-type="fig"}) ranged between 16 and 256 *μ*g/mL against Gram positive bacteria. Compound Co(L^1^)(OAc)·3H~2~O, Zn(L^1^)(OAc)·3H~2~O and Zn(L^2^)(OAc)·3H~2~O were found to be best, as they exhibit the lowest MIC of 32 *μ*g/mL against *S. aureus*and 16 *μ*g/mL against *B. subtilis* ([Table 6](#tab6){ref-type="table"}).

All the synthesized compounds screened for their antifungal activity, among these three compounds HL^1^, Co(L^1^)(OAc)·3H~2~O, and Co(L^1^)~2~·2H~2~O showed more than 55% inhibition of mycelial growth against*Aspergillus niger,* whereas three compounds HL^1^, Co(L^1^)(OAc)·3H~2~O, and Zn(L^1^)(OAc)·3H~2~O, showed more than 55% inhibition of mycelial growth against*A. flavus.*Co(L^1^)(OAc)·3H~2~O showed the highest inhibition of fungal mycelium (61%) against *A. flavus*([Table 7](#tab7){ref-type="table"}). Among all the tested chemical compounds, Co(L^1^)(OAc)·3H~2~O showed highest antibacterial and antifungal activity. The antimicrobial studies suggested that the Schiff bases were found to be biologically active and their metal complexes showed significantly enhanced antibacterial and antifungal activity against microbial strains in comparison to the free ligands. The overtone\'s concept \[[@B33]\] and Tweedy\'s chelation theory \[[@B34]\] can be used to explain the enhanced in antimicrobial activity of the metal complexes. According to the Overtone\'s concept of cell permeability, the lipid membrane surrounding the cell favors the passage of only lipid-soluble materials; therefore, liposolubility is an important factor which controls the antimicrobial activity. On chelation, polarity of the metal ion is reduced to a greater extent due the overlapping of the ligand orbital and partial sharing of the positive charge of the metal ion with donor groups. Moreover, delocalization of the π-electrons over the whole chelate ring is increased and lipophilicity of the complexes is enhanced. The increased lipophilicity enhances the penetration of the complexes into the lipid membranes and blocks the metal binding sites in the enzymes of microorganisms. These complexes also disturb the respiration process of the cell and thus block the synthesis of proteins, which restricts further growth of the organism. In general, metal complexes are more active than ligands as they may serve as principal cytotoxic species.

4. Conclusion {#sec4}
=============

The Schiff bases HL^1^ and HL^2^ coordinate in 1:1 and 1:2 metal-ligand ratios, as confirmed by analytical, IR, PMR, electronic, magnetic measurements, and thermal studies. The presence of coordinated water in metal complexes was confirmed by IR and TG studies. The trend in *g* values (*g* ~\|\|~ \> *g* ~⊥~ \> 2.00) suggested that the unpaired electron is localized in the *dx* ^2^-*y* ^2^ orbital and corresponds to square planar geometry of the copper complexes. Based on these, the proposed structures are shown in [Figure 4](#fig4){ref-type="fig"}. The antimicrobial studies suggested that the Schiff bases were found to be biologically active, and their metal complexes showed significantly enhanced antibacterial and antifungal activity against microbial strains in comparison to the free ligands. Thus, exhibiting their broad spectrum nature can be further used in pharmaceutical industry for mankind, as an antimicrobial agent, after testing its toxicity to human beings.
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###### 

IR spectral data of the ligands and their metal complexes (cm^−1^).

  Compound                *ν*(N=CH)   *ν*(C--S)   *ν*(S--H)   *ν*(OOCCH~3~)   *ν*(H~2~O/OH)   *ν*(M--S)   *ν*(M--N)
  ----------------------- ----------- ----------- ----------- --------------- --------------- ----------- -----------
  HL^1^                   1595        ---         2732        ---             ---             ---         ---
  Co(L^1^)(OAc)·3H~2~O    1585        741         ---         1744            3426            338         498
  Co(L^1^)~2~·2H~2~O      1585        743         ---         ---             3488            334         494
  Ni(L^1^)(OAc)·3H~2~O    1587        749         ---         1742            3471            342         510
  Ni(L^1^)~2~·2H~2~O      1588        733         ---         ---             3394            339         514
  Cu(L^1^)(OAc)·H~2~O     1590        748         ---         1744            3310            345         513
  Cu(L^1^)~2~             1589        750         ---         ---             ---             348         491
  Zn(L^1^)(OAc)·3H~2~O    1588        745         ---         1750            3441            352         489
  Zn(L^1^)~2~·2H~2~O      1585        748         ---         ---             3440            348         492
  HL^2^                   1597        ---         2703        ---             ---             ---         ---
  Co(L^2^)(OAc)·3H~2~O    1585        733         ---         1738            3294            344         485
  Co(L^2^)~2~·2H~2~O      1586        741         ---         ---             3310            338         488
  Ni(L^2^)(OAc) ·3H~2~O   1585        771         ---         1744            3280            338         489
  Ni(L^2^)~2~·2H~2~O      1587        755         ---         ---             3287            335         492
  Cu(L^2^)(OAc)·H~2~O     1585        733         ---         1746            3400            343         503
  Cu(L^2^)~2~             1586        733         ---         ---             ---             348         503
  Zn(L^2^)(OAc)·3H~2~O    1589        748         ---         1740            3318            347         500
  Zn(L^2^)~2~·2H~2~O      1589        771         ---         ---             3310            349         497

###### 

^1^H NMR spectral data of Schiff bases and their metal complexes.

  Compounds                                              ^1^H NMR (CDCl~3~/DMSO-d~6~) (ppm)
  ------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  HL^1^ \[C~10~H~8~Cl~2~N~4~S\]                          2.49 (s, 3H, --CH~3~), 7.35 (dd, 1H, Ar--H), 7.52 (d, 1H, Ar H), 8.08 (d, 1H, ArH), 10.40 (s, 1H, --N=CH--), 11.10 (s, 1H, --SH)
  Zn(L^1^)OAc·3H~2~O \[C~12~H~16~Cl~2~N~4~O~5~SZn\]      2.37 (s, 3H, --CH~3~), 7.41 (dd, 1H, Ar--H), 7.79 (d, 1H, Ar--H), 8.12 (d, 1H, Ar--H), 10.52 (s, 1H, --N=CH--), 2.29 (s, 3H, C[H]{.ul} ~3~COO)
  Zn(L^1^)~2~·2H~2~O \[C~20~H~18~Cl~4~N~8~O~2~S~2~Zn\]   2.58 (s, 3H, --CH~3~), 7.47 (dd, 1H, Ar--H), 7.78 (d, 1H, Ar--H), 8.08 (d, 1H, Ar--H), 10.58(s, 1H, --N=CH--)
  HL^2^ \[C~11~H~10~Cl~2~N~4~S\]                         2.84 (q, 2H, --C[H]{.ul} ~2~CH~3~), 1.35 (t, 3H, --CH~2~C[H]{.ul} ~3~), 7.35 (dd, 1H, Ar--H), 7.52 (d, 1H, Ar--H), 8.07 (d, 1H, Ar--H), 10.55 (s, 1H, --N=CH--), 11.09 (s, 1H, --SH)
  Zn(L^2^)OAc·3H~2~O \[C~13~H~18~Cl~2~N~4~O~5~SZn\]      2.67 (q, 2H, --C[H]{.ul} ~2~CH~3~), 1.22 (t, 3H, --CH~2~C[H]{.ul} ~3~), 7.43 (dd, 1H, Ar--H), 7.82 (d, 1H, Ar--H), 8.13 (d, 1H, Ar H), 10.61 (s, 1H, --N=CH--), 2.32 (s, 3H, C[H]{.ul} ~3~COO)
  Zn(L^2^)~2~·2H~2~O \[C~22~H~22~Cl~4~N~8~O~2~S~2~Zn\]   2.66 (q, 2H, --C[H]{.ul} ~2~CH~3~), 1.18 (t, 3H, --CH~2~C[H]{.ul} ~3~), 7.55 (dd, 1H, Ar--H), 7.83 (d, 1H, Ar--H), 8.13 (d, 1H, Ar H), 10.60 (s, 1H, --N=CH--)

###### 

Electronic spectral data of metal complexes.

  Compound               Transitions (cm^−1^)   Dq cm^−1^   B cm^−1^   *ν* ~2~/*ν* ~1~   *β*     *β*%           
  ---------------------- ---------------------- ----------- ---------- ----------------- ------- ------ ------- ------
  Co(L^1^)(OAc)·3H~2~O   10897                  23031\*     20998      1213.4            755.9   2.11   0.778   22.2
  Co(L^1^)~2~·2H~2~O     10885                  22884\*     20993      1199.9            748.1   2.10   0.770   23.0
  Ni(L^1^)(OAc)·3H~2~O   10117                  17201       24932      1011.7            785.4   1.70   0.754   24.5
  Ni(L^1^)~2~·2H~2~O     10123                  17320       24950      1012.3            793.4   1.71   0.762   23.7
  Co(L^2^)(OAc)·3H~2~O   10923                  23017\*     20010      1209.4            683.9   2.09   0.704   29.6
  Co(L^2^)~2~·2H~2~O     10935                  23041\*     20016      1210.6            683.5   2.10   0.703   29.6
  Ni(L^2^)(OAc)·3H~2~O   9999                   16380       24885      999.9             751.2   1.63   0.721   27.9
  Ni(L^2^)~2~·2H~2~O     9957                   16397       24889      995.7             761.0   1.64   0.731   26.9

\*Calculated value.

###### 

Thermoanalytical results (TG) of the metal complexes.

  ----------------------------------------------------------------------------------------------------------
  Compound             Steps   Temp. (°C)   TG mass%   Assignments   
  -------------------- ------- ------------ ---------- ------------- ---------------------------------------
  Cu(L^2^)~2~          1st\    80--305\     47.90\     45.29\        −C~14~H~8~Cl~4~ (organic moiety)\
                       2nd\    305--505\    21.26\     20.27\        −C~4~H~5~N~4~S (triazole ring)\
                       3rd     505--695     21.26\     20.05\        −C~4~H~5~N~4~S (triazole ring)\
                                            11.98      15.16         −CuO (residue)

  Zn(L^1^)~2~·2H~2~O   1st\    80--230\     5.37\      4.98\         −H~4~O~2~ (two water molecule)\
                       2nd\    230--560\    51.30\     51.50\        −C~14~H~8~Cl~4~N~2~ (organic moiety)\
                       3rd     560--700     33.73\     31.12\        −C~6~H~6~N~6~S~2~ (triazole ring)\
                                            11.90      12.40         −ZnO (residue)
  ----------------------------------------------------------------------------------------------------------

###### 

Antibacterial activity of synthesized compounds.

  Compound               Diameter of growth of inhibition zone   
  ---------------------- --------------------------------------- ------
  HL^1^                  19.0                                    21.3
  Co(L^1^)(OAc)·3H~2~O   23.6                                    25.6
  Co(L^1^)~2~·2H~2~O     16.6                                    19.6
  Ni(L^1^)(OAc)·3H~2~O   16.3                                    18.3
  Ni(L^1^)~2~·2H~2~O     14.6                                    19.6
  Cu(L^1^)(OAc)·H~2~O    20.3                                    18.3
  Cu(L^1^)~2~            15.6                                    17.0
  Zn(L^1^)(OAc)·3H~2~O   20.6                                    23.6
  Zn(L^1^)~2~·2H~2~O     19.3                                    20.6
  HL^2^                  17.3                                    18.3
  Co(L^2^)(OAc)·3H~2~O   16.6                                    19.3
  Co(L^2^)~2~·2H~2~O     17.6                                    20.6
  Ni(L^2^)(OAc)·3H~2~O   15.6                                    18.3
  Ni(L^2^)~2~·2H~2~O     15.0                                    16.6
  Cu(L^2^)(OAc)·H~2~O    16.3                                    18.5
  Cu(L^2^)~2~            19.6                                    21.2
  Zn(L^2^)(OAc)·3H~2~O   20.3                                    21.6
  Zn(L^2^)~2~·2H~2~O     18.3                                    19.6
  Ciprofloxacin          26.6                                    24.0

^a^Values, including diameter of the well (8 mm), are means of three replicates.

###### 

Minimum inhibitory concentration (MIC) (in *μ*g/mL) of compounds.

  Sr. No.   Compound               *Staphylococcus aureus*   *Bacillus subtilis*
  --------- ---------------------- ------------------------- ---------------------
  1         HL^1^                  64                        32
  2         Co(L^1^)(OAc)·3H~2~O   32                        16
  3         Co(L^1^)~2~·2H~2~O     64                        64
  4         Ni(L^1^)(OAc)·3H~2~O   128                       64
  5         Ni(L^1^)~2~·2H~2~O     128                       256
  6         Cu(L^1^)(OAc)·H~2~O    64                        128
  7         Cu(L^1^)~2~            128                       64
  8         Zn(L^1^)(OAc)·3H~2~O   32                        16
  9         Zn(L^1^)~2~·2H~2~O     128                       32
  10        HL^2^                  128                       32
  11        Co(L^2^)(OAc)·3H~2~O   64                        128
  12        Co(L^2^)~2~·2H~2~O     128                       32
  13        Ni(L^2^)(OAc)·3H~2~O   256                       128
  14        Ni(L^2^)~2~·2H~2~O     128                       64
  15        Cu(L^2^)(OAc)·H~2~O    256                       128
  16        Cu(L^2^)~2~            128                       32
  17        Zn(L^2^)(OAc)·3H~2~O   32                        16
  18        Zn(L^2^)~2~·2H~2~O     64                        32
  19        Ciprofloxacin          5                         5

###### 

Antifungal activity of synthesized compounds.

  Compound               Mycelial growth inhibition (%)   
  ---------------------- -------------------------------- ------
  HL^1^                  57.7                             58.8
  Co(L^1^)(OAc)·3H~2~O   58.8                             61.1
  Co(L^1^)~2~·2H~2~O     56.6                             55.5
  Ni(L^1^)(OAc)·3H~2~O   53.3                             55.5
  Ni(L^1^)~2~·2H~2~O     51.1                             47.7
  Cu(L^1^)(OAc)·H~2~O    50.0                             48.8
  Cu(L^1^)~2~            53.3                             52.5
  Zn(L^1^)(OAc)·3H~2~O   54.4                             56.6
  Zn(L^1^)~2~·2H~2~O     51.1                             50.0
  HL^2^                  48.8                             45.5
  Co(L^2^)(OAc)·3H~2~O   46.6                             47.7
  Co(L^2^)~2~·2H~2~O     48.8                             50.0
  Ni(L^2^)(OAc)·3H~2~O   44.4                             45.5
  Ni(L^2^)~2~·2H~2~O     45.5                             43.3
  Cu(L^2^)(OAc)·H~2~O    48.8                             50.0
  Cu(L^2^)~2~            52.5                             54.4
  Zn(L^2^)(OAc)·3H~2~O   53.3                             52.5
  Zn(L^2^)~2~·2H~2~O     50.0                             51.1
  Fluconazole            81.1                             77.7
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